CTNNB1
protein-codingcatenin beta 1, the group of Beta catenins|Armadillo repeat containing|Wnt enhanceosome complex
Gene summary
The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
- CTNNB
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~65.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0019516
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014035
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0033123
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0014035
Submitter: Illumina
CTNNB1 was first reported in relation to autosomal dominant CTNNB1-related severe intellectual disability-progressive spastic diplegia syndrom in 2012 (23033978: de Ligt et al. 2012). At least six unique loss of function variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level and experimental data. Variants in this gene have been reported in at least six probands from three publications (23033978: de Ligt et al. 2012; 25326669: Kuechler et al. 2015; 27915094: Kharbanda et al. 2017). Only de novo variants have been reported in literature. More evidence is available in the literature, but the maximum score for genetic evidence has been reached (12 pts.). The mechanism for disease is haploinsufficiency. This gene-disease association is supported by an animal model and in vitro functional assays (24614104: Tucci et al. 2014). In summary, there is strong evidence to support the relationship between CTNNB1 and CTNNB1-related severe intellectual disability-progressive spastic diplegia syndrome (autosomal dominant). Additional experimental evidence is required to reach a definitive classification.
Inheritance Pattern: AD
Disease ID:MONDO:0014035
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0033123
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: Unknown
Disease ID:MONDO:0014035
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0100571
Submitter: ClinGen
Heterozygous, usually *de novo*, germline variants in *CTNNB1* have been associated with CTNNB1-related neurodevelopmental disorder and/or vitreoretinopathy. The first report of *de novo* truncating variants in *CTNNB1* identified three unrelated patients with a common phenotype of severe intellectual disability with absent or very limited speech, microcephaly and spasticity (de Ligt et al., 2012, PMID: 23033978). Since then, more than 40 patients have been reported in the literature with *de novo* variants in *CTNNB1* (PMIDs: 24668549, 25326669, 27915094, 28514307, 33116939). The spectrum of disease has also expanded to include diagnoses of exudative vitreoretinopathy and other eye abnormalities, either in the presence of the aforementioned neurodevelopmental features or in isolation (PMIDs: 28514307, 28575650, 30640974, 32039639). Per criteria outlined by the ClinGen Lumping & Splitting guidelines and in consultation with the ClinGen Retina Gene Curation Expert Panel (GCEP), we have lumped severe intellectual disability-progressive spastic diplegia syndrome (MONDO:0014035, MIM #615075) and exudative vitreoretinopathy 7 (MONDO:0033123, MIM #617572) for the purposes of this curation. These two disease entities have been curated under the parent term *CTNNB1*-related neurodevelopmental disorder and/or vitreoretinopathy. Both disease entities can exhibit similar defects in retinal vascularization that lead to serous retinal detachment and other ocular features. The proposed disease mechanism is haploinsufficiency, and the observed variant spectrum is similar in both presentations, with the majority of identified variants being nonsense and frameshift variants. There has also been at least one report of a single frameshift variant causing both the syndromic neurodevelopmental presentation and the isolated ocular presentation in unrelated individuals (PMIDs: 28575650, 30929091). Since vitreoretinopathy has been reported in cases without neurodevelopmental features and vice versa (PMIDs: 28575650, 30640974), further investigation of genotype-phenotype correlation and more complete characterization of patients over a longer period of time may be required to better understand the frequency and etiology of isolated phenotypes. *CTNNB1* encodes β-catenin, a component of the cadherin adhesion complex which mediates cell-cell adhesion, and is also part of the Wnt signaling pathway, important for controlling cell growth and differentiation. Experimental evidence *in vitro* and *in vivo* in a mouse model further support the role of *CTNNB1* in disease. In summary, there is definitive evidence supporting the relationship between *CTNNB1* and *CTNNB1*-related neurodevelopmental disorder and/or vitreoretinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was originally evaluated by the ClinGen Intellectual Disability and Autism GCEP on February 3, 2021. It was reevaluated by the Retina GCEP and Intellectual Disability and Autism GCEP on February 8, 2024 (SOP 11), resulting in the change of the disease name as discussed above. The classification, however, did not change.
Inheritance Pattern: AD
Disease ID:MONDO:0019516
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014035
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CTNNB1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001904.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 161 | 6 | 173 | |
| missense | 10 | 24 | 353 | 19 | 406 | |
| nonsense | 46 | 12 | 1 | 59 | ||
| start loss | 1 | 1 | ||||
| frameshift | 109 | 29 | 1 | 139 | ||
| splice donor/acceptor (+/-2bp) | 16 | 18 | 10 | 44 | ||
| Total | 182 | 83 | 371 | 180 | 6 | 822 |
Highest pathogenic variant AF is 0.0000024783023
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001895.1 | 14 | MANE Select | |
| Ensembl | ENSP00000344456.5 | 14 | MANE Select | |
| RefSeq | NP_001091679.1 | 14 | Standard | |
| RefSeq | NP_001091680.1 | 14 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ctnnb1 | Danio rerio | Structure: post-vent region Quality: curved ventral abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gastric cancer - Homo sapiens (human)
- Focal adhesion - Homo sapiens (human)
- Kaposi,s sarcoma-associated herpesvirus infection - Homo sapiens (human)
- Adherens junction - Homo sapiens (human)
- Cushing,s syndrome - Homo sapiens (human)
Biological Process
- negative regulation of transcription by RNA polymerase II
- embryonic axis specification
- cell morphogenesis involved in differentiation
- branching involved in blood vessel morphogenesis
- branching involved in ureteric bud morphogenesis
Molecular Function
- RNA polymerase II transcription factor binding
- RNA polymerase II activating transcription factor binding
- chromatin binding
- DNA-binding transcription factor activity
- transcription coactivator activity
Cellular Component
- spindle pole
- nucleus
- nucleoplasm
- transcription factor complex
- nuclear euchromatin
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000349496
- Coding exons
- 14
- Length
- 65260
- Individuals with no LoFs
- 125682
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 125683
- p
- 0.00000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.85 | 199 | 421 | 0.473 | 0.0000246 | 5096 |
| Missense (PolyPhen) | 22 | 76.428 | 0.28785 | 982 | ||
| Synonymous | 0.139 | 139 | 141 | 0.985 | 0.00000713 | 1589 |
| Loss of Function | 5.46 | 1 | 36.7 | 0.0272 | 0.00000226 | 409 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Key downstream component of the canonical Wnt signaling pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes. Involved in the regulation of cell adhesion, as component of an E- cadherin:catenin adhesion complex. Acts as a negative regulator of centrosome cohesion. Involved in the CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization. Blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating DAPK2. Disrupts PML function and PML-NB formation by inhibiting RANBP2-mediated sumoylation of PML (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:18957423, PubMed:21262353, PubMed:22647378, PubMed:22699938, PubMed:22155184). Promotes neurogenesis by maintaining sympathetic neuroblasts within the cell cycle (By similarity). {ECO:0000250|UniProtKB:Q02248, ECO:0000269|PubMed:17524503, ECO:0000269|PubMed:18077326, ECO:0000269|PubMed:18086858, ECO:0000269|PubMed:18957423, ECO:0000269|PubMed:21262353, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22647378, ECO:0000269|PubMed:22699938}.;
- Disease
- DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. {ECO:0000269|PubMed:9065402}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Note=Activating mutations in CTNNB1 have oncogenic activity resulting in tumor development. Somatic mutations are found in various tumor types, including colon cancers, ovarian and prostate carcinomas, hepatoblastoma (HB), hepatocellular carcinoma (HCC). HBs are malignant embryonal tumors mainly affecting young children in the first three years of life.; DISEASE: Pilomatrixoma (PTR) [MIM:132600]: Common benign skin tumor. {ECO:0000269|PubMed:10192393, ECO:0000269|PubMed:11703283, ECO:0000269|PubMed:12027456}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Medulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. {ECO:0000269|PubMed:10666372, ECO:0000269|PubMed:12027456}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10391090}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving CTNNB1 is found in salivary gland pleiomorphic adenomas, the most common benign epithelial tumors of the salivary gland. Translocation t(3;8)(p21;q12) with PLAG1.; DISEASE: Mesothelioma, malignant (MESOM) [MIM:156240]: An aggressive neoplasm of the serosal lining of the chest. It appears as broad sheets of cells, with some regions containing spindle- shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. {ECO:0000269|PubMed:11464291}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Mental retardation, autosomal dominant 19 (MRD19) [MIM:615075]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD19 features include severe intellectual disability with absent or very limited speech, microcephaly, and spasticity which severely impaired the ability to walk. {ECO:0000269|PubMed:23033978, ECO:0000269|PubMed:25326669, ECO:0000269|PubMed:28514307}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Vitreoretinopathy, exudative 7 (EVR7) [MIM:617572]: A form of exudative vitreoretinopathy, a disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. {ECO:0000269|PubMed:28575650}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.996
Intolerance Scores
- LoFtool
- 0.208
- RVIS EVS
- -0.58
- RVIS percentile EVS
- 18.44
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 1.00
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |